GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Interest Expense

DT&CRO Co (XKRX:383930) Interest Expense : ₩-711 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. DT&CRO Co's interest expense for the three months ended in Jun. 2024 was ₩ -426 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was ₩-711 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. DT&CRO Co's Operating Income for the three months ended in Jun. 2024 was ₩ -4,071 Mil. DT&CRO Co's Interest Expense for the three months ended in Jun. 2024 was ₩ -426 Mil. DT&CRO Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


DT&CRO Co Interest Expense Historical Data

The historical data trend for DT&CRO Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Interest Expense Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Interest Expense
-113.62 -119.40 -61.53 -147.81

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 78.88 -83.77 -64.04 -137.34 -425.86

DT&CRO Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-711 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DT&CRO Co  (XKRX:383930) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

DT&CRO Co's Interest Expense for the three months ended in Jun. 2024 was ₩-426 Mil. Its Operating Income for the three months ended in Jun. 2024 was ₩-4,071 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was ₩10,715 Mil.

DT&CRO Co's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

DT&CRO Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


DT&CRO Co Business Description

Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co Headlines

No Headlines